Is It Time to Test the Antiseizure Potential of Palmitoylethanolamide in Human Studies? A Systematic Review of Preclinical Evidence

Antiseizure medications are the cornerstone pharmacotherapy for epilepsy. They are not devoid of side effects. In search for better-tolerated antiseizure agents, cannabinoid compounds and other N-acylethanolamines not directly binding cannabinoid receptors have drawn significant attention. Among the...

Descripción completa

Detalles Bibliográficos
Autores principales: Bortoletto, Riccardo, Balestrieri, Matteo, Bhattacharyya, Sagnik, Colizzi, Marco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Systematic Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8773576/
https://www.ncbi.nlm.nih.gov/pubmed/35053844
http://dx.doi.org/10.3390/brainsci12010101

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8773576/
https://www.ncbi.nlm.nih.gov/pubmed/35053844
http://dx.doi.org/10.3390/brainsci12010101

Ejemplares similares